Company intelligence / Profile preview

Nipro Pharma

Osaka, Osaka, Japan

Ownership: Private
Employees: ~2800
Development stage: Other

Overview

Nipro Pharma is Japan's leading contract development and manufacturing organization (CDMO) for pharmaceuticals. A core member of the Nipro Group, the company provides end-to-end services ranging from formulation research and clinical trial material production to full-scale commercial manufacturing across various dosage forms, with a particular strength in sterile injectables and complex drug delivery systems.

Modalities: Small moleculeBiologicPeptidesVaccine
Industry: Contract Manufacturing Organization

Partnerships

AstraZenecaTakedaDaiichi SankyoShionogi

Beyond the preview

Go deeper on Nipro Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nipro Pharma.

Explore the full profile